Item 3.01. | Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. |
On November 25, 2024, FiscalNote Holdings, Inc. (the “Company”) received notice from the New York Stock Exchange (the “NYSE”) stating that it has concluded that the Company is not in compliance with Rule 802.01C of the NYSE’s continued listing requirements (the “NYSE Notification”), since as of November 20, 2024, the 30-trading day average closing price of the Company’s shares of Class A common stock, par value $0.0001 per share (the “Common Stock”) had fallen below $1.00 per share over a consecutive 30 trading-day period. Within 10 business days of receipt of the NYSE Notification, the Company must notify the NYSE of its intent to cure this deficiency or be subject to suspension and delisting procedures; the Company intends to notify the NYSE of its intent to cure the deficiency within this 10 business day period.
The Company has a six-month cure period following the receipt of the NYSE Notification to regain compliance with the minimum share price requirement. To regain compliance, on the last trading day of any calendar month during the cure period, the Common Stock must have (i) a closing price of at least $1.00 per share and (ii) an average closing price of at least $1.00 per share over the 30-trading day period ending on the last trading day of such month. If both of these conditions are not met by the end of the cure period, the NYSE will commence suspension and delisting procedures. In response, the Company’s Board of Directors is reviewing all available alternatives to return to compliance with the NYSE continued listing standards.
The NYSE Notification does not affect the Company’s business operations or its Securities and Exchange Commission reporting requirements, has no immediate effect on the listing of the Common Stock on the NYSE, and does not conflict with or cause an event of default under any of the Company’s material debt agreements.
Item 7.01 | Regulation FD Disclosure. |
On November 29, 2024, the Company issued a press release with respect to its receipt of the NYSE Notification.
The information disclosed under Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.